VOLUME 67   2006   SUPPLEMENT 3

The Alzheimer's Disease Continuum:
 From Neuropathology to Clinical Practice

CME Background Information
[PDF]

ARTICLES

3 Neuropathologic Changes in Alzheimer's Disease: Potential Targets for Treatment. Gary L. Wenk
[Abstract] [PDF]

8 Navigating Patients and Caregivers Through the Course of Alzheimer's Disease. Peter M. Aupperle
[Abstract] [PDF]

15 Contemporary Issues in the Treatment of Alzheimer's Disease: Tangible Benefits of Current Therapies. Pierre N. Tariot
[Abstract] [PDF]

CME Section

23 Instructions and Posttest.
[PDF]

24 Registration Form and Evaluation.
[PDF]

Editor’s Choice

Alzheimer's disease is one of the most feared diagnoses for our patients and their families. This supplement starts with an overview by Gary L. Wenk, Ph.D., of the therapeutic targets being explored to expand treatment options. Next, Peter M. Aupperle, M.D., M.P.H., provides an excellent clinical guide to the detection, assessment, and management of Alzheimer's disease, including practical tips on the use of cholinesterase inhibitors and memantine. Finally, Pierre N. Tariot, M.D., defines the benefits from currently available therapies, a review that can be very helpful in counseling families regarding the potential significant improvements in cognition, function, and quality of life to be derived from treatment. The new insights from this supplement update the clinician with the key information required to optimize care for those at all stages of Alzheimer's disease.

Larry Culpepper, MD, MPH

Editor in Chief

The Primary Care Companion to the Journal of Clinical Psychiatry